Newsletters

Two Kolling Institute researchers have welcomed a significant funding boost through a large NSW Government program to help tackle Australia’s number one killer, heart disease. Professors Gemma Figtree and Martin Ugander have each been awarded a $750,000 grant to encourage researchers to find breakthroughs and help establish NSW as a centre for research excellence. The

Read more

The latest exciting research into musculoskeletal disease has been unveiled during the inaugural Northern Lights showcase. Close to 200 people attended the jam packed event in the Kolling auditorium, including clinicians, researchers and many people living with arthritic pain. RNSH Head of Rheumatology Professor Lyn March addressed the event, detailing the devastating cost of the

Read more

Research capabilities within the Kolling Institute have been significantly broadened with new technology to assist the examination of bowel cancer. Representatives from Sydney University, the Kolling and Bowel Cancer Australia attended the official opening of the mass spectrometry core lab – the first of its type on a hospital campus and one of the best

Read more

Read more

Read more

A study has been launched to investigate the benefits of a new injectable medication for those with knee osteoarthritis. The condition can have a profound impact on a person’s life, leading to physical limitations, ongoing pain and joint instability. There are broader implications too which can make it difficult for those with the condition to

Read more

Kolling researchers are part of an international team calling for musculoskeletal health to become a global priority, addressing a current lack of funding for the world’s leading cause of pain. The project team found the management of musculoskeletal health is under-prioritised despite its impact on the community, and devised an action plan to address this

Read more